Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page
- Check7 days agoChange DetectedRevision history now shows v3.6.6 in place of v3.6.5, indicating a software patch release. The change records an update to the underlying system version, not a modification of page content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, signaling a new site revision behind the page. This likely includes minor fixes or enhancements without changing the study content or how the data is presented.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision indicator was updated from v3.6.3 to v3.6.4, reflecting an administrative update to the page. No substantive study content or functionality was changed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page shows a new revision label v3.6.3 replacing v3.6.2. This indicates a small deployment update and does not alter the study information.SummaryDifference0.1%

- Check71 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer version of the page documentation. This update does not modify the study details or user-visible content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now indicates recruitment has ended and adds new help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was adjusted and the revision tag was updated to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.